Neurobiology of Opioid Dependence: 4 - 4

Phase 2

Withdrawn

• Conditions: Opioid-Related Disorders

• Registration Number: NCT00000195
• Lead Sponsor: Yale University

Brief Summary

The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers.

Detailed Description

Not available

Study Timeline

• Study Start: 1993-01
• Primary Completion: 1998-01
• Study Completion: 1998-01
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Status Verified: 2015-08
• Last Update Submitted: 2016-05-05
• Last Update Posted: 2016-05-06

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Behavioral, physiological, neuroendocrine response to yohimine

Trial Locations

Locations (1)

VA Connecticut Healthcare System; 🇺🇸 New Haven, Connecticut, United States